Nanotechnology special issue spotlights smart platforms while advancing precision cancer therapy
Peer-Reviewed Publication
Updates every hour. Last Updated: 7-Jun-2026 03:15 ET (7-Jun-2026 07:15 GMT/UTC)
Nanotechnology is emerging as a transformative force in cancer research, but the future of precision oncology will not be defined by drug delivery alone.
Influenza viruses, long known as harmful human pathogens, are now being reengineered into safe and powerful therapeutic tools. A new article in Engineering introduces a controllable PTC influenza platform using non-canonical amino acids to limit viral replication while boosting immune protection. This versatile system works as a next-generation vaccine against flu and other infections and shows strong potential as a cancer immunotherapy tool, opening new paths for future infectious disease and cancer treatments.
The effects of the Iran war on the oil market have brought renewed attention to the EU’s plans for domestic production of fossil-free aviation fuels. But EU rules for synthetic aviation fuels risk steering development towards production pathways that are both more expensive and more energy-intensive than necessary – making it harder to meet climate targets. This is shown in a recent study from Chalmers University of Technology, Sweden, that has analysed different methods for producing synthetic methanol.
Stevia is a widely used sweetener, but why do some stevia varieties taste cleaner and more sugar-like than others? Recent research conducted at the University of Toyama shows that stevia’s sweetness is genetically linked to variations in specific glycosyltransferase genes and their cell-specific activity in leaves. By combining genetic analysis with cell-level imaging, the team uncovered how stevia produces its high-value sweet compounds, opening the door to better-tasting natural sweeteners for foods and beverages.
Basilar trunk artery aneurysms are a rare and serious type of brain aneurysm with limited treatment data. A study finds that most patients can be successfully treated using minimally invasive procedures, with nearly nine in ten achieving good recovery. Based on one of the largest single-center analyses to date, this study highlights the effectiveness of modern endovascular techniques while pointing to higher risks in larger aneurysms, emphasizing the need for careful patient selection and follow-up.